We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $17.6M invested in Seelos Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

396% more capital invested

Capital invested by funds: $3.56M → $17.6M (+$14.1M)

19% more call options, than puts

Call options by funds: $203K | Put options by funds: $170K

0% more funds holding

Funds holding: 2 → 2 (0)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
–
Increased
1
Reduced
–
Closed
–
Calls
$203K
Puts
$170K
Net Calls
+$33K
Net Calls Change
+$94K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sarissa Capital Management
Connecticut
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$112K
2
SIM
Spark Investment Management
New York
-$74K
3
Renaissance Technologies
Renaissance Technologies
New York
-$54K
4
RG
Rathbones Group
United Kingdom
-$25K
5
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$12.2M +$10.3M +5 +500%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.4M – – –
HVC
3
Healthcare Value Capital
New Jersey
$935K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$471K – – –
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$315K – – –
BFA
6
BlackRock Fund Advisors
California
$217K – – –
Northern Trust
7
Northern Trust
Illinois
$169K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$118K – – –
CC
9
Callan Capital
California
$104K – – –
BIP
10
Brandes Investment Partners
California
$100K – – –
Franklin Resources
11
Franklin Resources
California
$98K – – –
RCM
12
Rotella Capital Management
Washington
$79K – – –
HighTower Advisors
13
HighTower Advisors
Illinois
$73K – – –
Millennium Management
14
Millennium Management
New York
$54K – – –
Bank of America
15
Bank of America
North Carolina
$50K – – –
EEG
16
E.E. Geduld
$47K – – –
Morgan Stanley
17
Morgan Stanley
New York
$35K – – –
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$35K – – –
BA
19
BlackRock Advisors
Delaware
$31K – – –
FANJ
20
Financial Architects (New Jersey)
New Jersey
$19K – – –
State Street
21
State Street
Massachusetts
$19K – – –
BIM
22
BlackRock Investment Management
Delaware
$12K – – –
AIG
23
American International Group
New York
$11.5K – – –
Creative Planning
24
Creative Planning
Kansas
$11K – – –
Group One Trading
25
Group One Trading
Illinois
$11K – – –
1
2

SEEL Hedge Fund Activity: Q1 2015 in Review

2 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2015, worth a combined $17.6M — up 396% from $3.56M a quarter earlier.

Fund positioning in SEEL was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Sarissa Capital Management, adding an estimated $10.3M. The largest seller was Virtu KCG Holdings, cutting an estimated $112K.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $17.6M of Seelos Therapeutics, Inc. Common Stock stock for Q1 2015, up 396% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2015 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q1 2015 was Sarissa Capital Management, an estimated $10.3M added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2015 was Virtu KCG Holdings, an estimated $112K sold.

Based on aggregated 13F filings for Q1 2015.